The Impact of the "Humira Effect" and Autoimmune Trends...

ha aggiunto un file Health

2026-04-02 12:11:01 -

The Impact of the "Humira Effect" and Autoimmune Trends in the US Biosimilars Market

The landscape of chronic disease management is being permanently altered by the "Biosimilar Wave" of the mid-2020s. In 2026, the US Biosimilars Market is seeing the full maturity of the adalimumab (Humira) market, which served as a "Stress Test" for the American healthcare system. With more than 10 competitors now available for this single molecule, list prices have dropped significantly, and...

0 Commenti 0 condivisioni 263 Views 0 Anteprima

Install Ework Face